Mechanism Underlying Increase of the Serum Magnesium Concentration Observed Following Treatment with Sodium-Glucose Cotransporter 2 Inhibitors

ISSN Print: 2160-5831
ISSN Online: 2160-5858
www.scirp.org/journal/jdm
E-mail: jdm@scirp.org

Citations

"Mechanism Underlying Increase of the Serum Magnesium Concentration Observed Following Treatment with Sodium-Glucose Cotransporter 2 Inhibitors"
written by Yasuhiro Sasaki, Keiko Koyano, Shuhei Iida, Tatsuo Yanagawa,
published by Journal of Diabetes Mellitus, Vol.7 No.4, 2017

has been cited by the following article(s):

[1]	Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis
	American Journal of Kidney Diseases, 2024

[2]	The Role of Sodium-Glucose Co-transporter 2 Inhibitors in Patients With Hypomagnesemia: A Systematic Review
	Cureus, 2024

[3]	The Micro Mechanism and Nursing of the Treatment of Gastric Ulcer Combined with Gastric Hemorrhage with Aluminum Magnesium Carbonate.
	2020

[1]	Verification of the Short-term Effect of SGLT2 Inhibitors on Serum Magnesium Stratified by the Classification of Albuminuria Severity in Patients with Type 2 Diabetes Mellitus Internal Medicine, 2026 DOI:10.2169/internalmedicine.6548-25

[2]	Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review American Journal of Kidney Diseases, 2024 DOI:10.1053/j.ajkd.2023.11.006

[3]	The Role of Sodium-Glucose Co-transporter 2 Inhibitors in Patients With Hypomagnesemia: A Systematic Review Cureus, 2024 DOI:10.7759/cureus.60919

[4]	SGLT2 inhibitors increase low serum magnesium levels in patients with chronic kidney disease immediately after treatment Clinical and Experimental Nephrology, 2024 DOI:10.1007/s10157-024-02590-8